Disease | hyperthermia |
Comorbidity | C0242379|lung cancer |
Sentences | 10 |
PubMedID- 24679653 | We assessed the efficacy and safety of cefepime monotherapy (1 g intravenously every 8 h) for febrile neutropenia in patients with lung cancer in a multi-institutional phase ii study. |
PubMedID- 21773751 | Identifying risk factors for refractory febrile neutropenia in patients with lung cancer. |
PubMedID- 23053498 | Elevation of serum c-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer. |
PubMedID- 21707992 | Bacterial infection profiles in lung cancer patients with febrile neutropenia. |
PubMedID- 26024659 | Psychogenic fever in a patient with small cell lung cancer: a case report. |
PubMedID- 19699672 | In this report, we describe an unusual case of non-metastatic non-small cell lung cancer (nsclc) presenting with neoplastic fever at both diagnosis and relapse, responding on each occasion to disease-specific treatment, and provide a review of the management of neoplastic fever. |
PubMedID- 26082648 | A 30-year-old female patient previously treated with crizotinib harboring alk rearranged non-small cell lung cancer complained of visual disturbance, fever, and bone pains undergoing anti-pd-1 antibody treatment. |
PubMedID- 26434104 | Pentraxin-3 as a biomarker for febrile neutropenia in patients with lung cancer. |
PubMedID- 20130951 | Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer. |
PubMedID- 22085873 | Discussion and conclusions: though rare, aosd-like pns can be one of the potential diagnoses in lung cancer patients with fever of undetermined origin, especially those having no response to antibiotic treatment. |
Page: 1